89 related articles for article (PubMed ID: 21612933)
1. New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis.
Andrzejak V; Muccioli GG; Body-Malapel M; El Bakali J; Djouina M; Renault N; Chavatte P; Desreumaux P; Lambert DM; Millet R
Bioorg Med Chem; 2011 Jun; 19(12):3777-86. PubMed ID: 21612933
[TBL] [Abstract][Full Text] [Related]
2. Switching cannabinoid response from CB(2) agonists to FAAH inhibitors.
Tourteau A; Leleu-Chavain N; Body-Malapel M; Andrzejak V; Barczyk A; Djouina M; Rigo B; Desreumaux P; Chavatte P; Millet R
Bioorg Med Chem Lett; 2014 Mar; 24(5):1322-6. PubMed ID: 24508127
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of potent FAAH inhibitors.
Tuo W; Leleu-Chavain N; Barczyk A; Renault N; Lemaire L; Chavatte P; Millet R
Bioorg Med Chem Lett; 2016 Jun; 26(11):2701-5. PubMed ID: 27117424
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold.
Morera L; Labar G; Ortar G; Lambert DM
Bioorg Med Chem; 2012 Nov; 20(21):6260-75. PubMed ID: 23036333
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.
Wang X; Sarris K; Kage K; Zhang D; Brown SP; Kolasa T; Surowy C; El Kouhen OF; Muchmore SW; Brioni JD; Stewart AO
J Med Chem; 2009 Jan; 52(1):170-80. PubMed ID: 19072118
[TBL] [Abstract][Full Text] [Related]
6. Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.
Mor M; Rivara S; Lodola A; Plazzi PV; Tarzia G; Duranti A; Tontini A; Piersanti G; Kathuria S; Piomelli D
J Med Chem; 2004 Oct; 47(21):4998-5008. PubMed ID: 15456244
[TBL] [Abstract][Full Text] [Related]
7. A fluorinated analog of ISO-1 blocks the recognition and biological function of MIF and is orally efficacious in a murine model of colitis.
Dagia NM; Kamath DV; Bhatt P; Gupte RD; Dadarkar SS; Fonseca L; Agarwal G; Chetrapal-Kunwar A; Balachandran S; Srinivasan S; Bose J; Pari K; B-Rao C; Parkale SS; Gadekar PK; Rodge AH; Mandrekar N; Vishwakarma RA; Sharma S
Eur J Pharmacol; 2009 Apr; 607(1-3):201-12. PubMed ID: 19239912
[TBL] [Abstract][Full Text] [Related]
8. 3-Heterocycle-phenyl N-alkylcarbamates as FAAH inhibitors: design, synthesis and 3D-QSAR studies.
Käsnänen H; Myllymäki MJ; Minkkilä A; Kataja AO; Saario SM; Nevalainen T; Koskinen AM; Poso A
ChemMedChem; 2010 Feb; 5(2):213-31. PubMed ID: 20024981
[TBL] [Abstract][Full Text] [Related]
9. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.
Calí P; Naerum L; Mukhija S; Hjelmencrantz A
Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716
[TBL] [Abstract][Full Text] [Related]
10. Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases.
Huang TY; Chu HC; Lin YL; Lin CK; Hsieh TY; Chang WK; Chao YC; Liao CL
Toxicol Appl Pharmacol; 2009 May; 237(1):69-82. PubMed ID: 19285099
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets.
Zhang D; Saraf A; Kolasa T; Bhatia P; Zheng GZ; Patel M; Lannoye GS; Richardson P; Stewart A; Rogers JC; Brioni JD; Surowy CS
Neuropharmacology; 2007 Mar; 52(4):1095-105. PubMed ID: 17217969
[TBL] [Abstract][Full Text] [Related]
12. Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
Vincent F; Nguyen MT; Emerling DE; Kelly MG; Duncton MA
Bioorg Med Chem Lett; 2009 Dec; 19(23):6793-6. PubMed ID: 19850474
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of FAAH inhibitors: cyclohexylcarbamic acid biphenyl esters with chemical modulation at the proximal phenyl ring.
Tarzia G; Duranti A; Gatti G; Piersanti G; Tontini A; Rivara S; Lodola A; Plazzi PV; Mor M; Kathuria S; Piomelli D
ChemMedChem; 2006 Jan; 1(1):130-9. PubMed ID: 16892344
[TBL] [Abstract][Full Text] [Related]
14. Binding mode of new (thio)hydantoin inhibitors of fatty acid amide hydrolase: comparison with two original compounds, OL-92 and JP104.
Michaux C; Muccioli GG; Lambert DM; Wouters J
Bioorg Med Chem Lett; 2006 Sep; 16(18):4772-6. PubMed ID: 16844375
[TBL] [Abstract][Full Text] [Related]
15. Piperidinyl thiazole isoxazolines: A new series of highly potent, slowly reversible FAAH inhibitors with analgesic properties.
Pember SO; Mejia GL; Price TJ; Pasteris RJ
Bioorg Med Chem Lett; 2016 Jun; 26(12):2965-2973. PubMed ID: 27130358
[TBL] [Abstract][Full Text] [Related]
16. Structure based design of novel irreversible FAAH inhibitors.
Wang JL; Bowen SJ; Schweitzer BA; Madsen HM; McDonald J; Pelc MJ; Tenbrink RE; Beidler D; Thorarensen A
Bioorg Med Chem Lett; 2009 Oct; 19(20):5970-4. PubMed ID: 19765986
[TBL] [Abstract][Full Text] [Related]
17. 1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A(2)alpha and fatty acid amide hydrolase.
Forster L; Ludwig J; Kaptur M; Bovens S; Elfringhoff AS; Holtfrerich A; Lehr M
Bioorg Med Chem; 2010 Jan; 18(2):945-52. PubMed ID: 20005725
[TBL] [Abstract][Full Text] [Related]
18. Identification of productive inhibitor binding orientation in fatty acid amide hydrolase (FAAH) by QM/MM mechanistic modelling.
Lodola A; Mor M; Rivara S; Christov C; Tarzia G; Piomelli D; Mulholland AJ
Chem Commun (Camb); 2008 Jan; (2):214-6. PubMed ID: 18092091
[TBL] [Abstract][Full Text] [Related]
19. New halogenated phenylcoumarins as tyrosinase inhibitors.
Matos MJ; Santana L; Uriarte E; Delogu G; Corda M; Fadda MB; Era B; Fais A
Bioorg Med Chem Lett; 2011 Jun; 21(11):3342-5. PubMed ID: 21514152
[TBL] [Abstract][Full Text] [Related]
20. Application of a FLAP-consensus docking mixed strategy for the identification of new fatty acid amide hydrolase inhibitors.
Poli G; Giuntini N; Martinelli A; Tuccinardi T
J Chem Inf Model; 2015 Mar; 55(3):667-75. PubMed ID: 25746133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
